$27.51
+3.5%Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
HIMS โข NYSE
| Hims & Hers Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
2.3B | 1.5B | 872M | 526.9M | 271.9M | 148.8M | 82.6M | |
GROSS PROFIT | |||||||
(614.3M) | (303.4M) | (157.1M) | (118.2M) | (67.4M) | (39.3M) | (38M) | |
1.7B | 1.2B | 714.9M | 408.7M | 204.5M | 109.5M | 44.6M | |
OPERATING INCOME | |||||||
(1.6B) | (1.1B) | (744.4M) | (477.4M) | (319.5M) | (124.6M) | (119M) | |
(1.2B) | (846.6M) | (576.3M) | (370.8M) | (249.6M) | (113.4M) | (119M) | |
(149.3M) | (78.8M) | (48.2M) | (29.2M) | (22.4M) | (11.2M) | (0.0) | |
105.6M | 61.9M | -29.5M | -68.7M | -115M | -15.1M | -74.4M | |
PRE-TAX INCOME | |||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (10K) | (369K) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10K | -369K | |
(286.4M) | (185.8M) | (119.9M) | (77.4M) | (47.6M) | (0.0) | (0.0) | |
18.3M | 9.8M | 7.9M | 3M | 4.2M | -2.8M | 2.4M | |
123.9M | 71.7M | -21.6M | -65.7M | -110.8M | -18M | -72M | |
NET INCOME | |||||||
-4.4M | -54.3M | (2M) | -31K | -3.1M | (127K) | (90K) | |
128.4M | 126M | -23.5M | -65.7M | -107.7M | -18.1M | -72.1M |
HIMS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | May 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 21, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 19, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 11, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 11, 2026 | March 09, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 23, 2026 | February 23, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 23, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 19, 2026 | February 19, 2026 | 2026 |
Continue your HIMS research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.